New iron supplement shows promise for anemia relief

NCT ID NCT07483645

Ongoing Disease control Sponsor: Carnot Laboratories Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing a liposomal iron supplement with vitamin C and fiber (LISEFEX®) in 74 Mexican adults with mild to moderate iron deficiency anemia. Researchers are observing how well the supplement raises hemoglobin levels and how acceptable it is to patients. The supplement is prescribed by doctors as part of routine care, and the study simply collects data during follow-up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Liposomal iron supplement with vitamin C and fiber (LISEFEX®)
What this could lead to: If effective, this supplement could offer a better-tolerated option to raise hemoglobin levels in people with mild to moderate iron deficiency anemia.
What could go wrong: This is a small observational study without a control group, so results may not prove the supplement works better than standard iron. Side effects like stomach upset are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRON DEFICIENCY ANEMIA

Contacts and locations

Locations

Winsett Rethman S.A. de C.V.

Monterrey, Nuevo León, 64040, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.